NVO - Eli Lilly's Mounjaro Zepbound to remain in shortage through end of Q2
2024-04-17 12:02:34 ET
More on Eli Lilly
- Wall Street Lunch: Lilly In Limelight
- Eli Lilly: Three Threats To Its Huge Rally
- Why Eli Lilly And Rival Novo Nordisk Won't Be Troubled By Viking's Latest Weight Loss Data
- Eli Lilly obesity therapy succeeds in late-stage trials for sleep disorder
- GLP-1s benefit Parkinson’s: Barclays sees implications across biopharma